Imaging Platform

Clario's Imaging Platform is a clinical trial imaging solution built around proprietary systems and in-house medical expertise. It is designed for sponsors and research teams running clinical trials of varying complexity, offering an alternative to third-party imaging applications by providing dedicated engineering, bespoke workflows, and integrated quality control within a single platform.

Clario positions itself as an Imaging Core Lab with more than 30 physicians and 35 scientists focused on medical and clinical trial imaging. This internal expertise has directly informed the development of its proprietary imaging systems, including the SMART Submit application, which screens medical images for errors at the point of hospital submission through to final image interpretation.

Core Platform Capabilities

• Proprietary imaging workstations developed by over 250 dedicated engineering staff, avoiding reliance on third-party clinical care software with limited functionality.
• Segmentation algorithms, novel workflows, and custom reporting methods tailored to reflect the complexity of individual study protocols.
• Ability to reconcile images against Electronic Data Capture (EDC) data within the platform, or export data for import into a third-party EDC system.
• Online image viewing functionality integrated into the platform.
• Pre-submission image screening to reduce risk, lower costs, and avoid study delays.

Artificial Intelligence Features

• Custom AI solutions developed to address specific trial needs, covering all medical imaging modalities and therapeutic areas.
• AI deployed in a compliant manner, drawing on Clario's experience as a provider of medical imaging services for clinical trials.
• AI applied to every image read to increase accuracy and reduce inter-reader variability.
• Capability to create and validate AI models for identifying novel imaging biomarkers, combining imaging expertise with AI development.

Quality Control and Efficiency

• Automatic quality control processes that result in a 6- to 48-fold reduction in common imaging issues, such as submission of incorrect patient images or inclusion of unredacted Protected Health Information (PHI).
• Elimination of additional cost and time layers associated with third-party system customization.
• Streamlined workflows designed to minimize delays across the study lifecycle.

The platform is built entirely on Clario's proprietary technology and staffed by in-house medical and engineering teams, which the company states removes the costs and delays typically associated with third-party imaging solutions. It supports integration with external EDC systems and is applicable across a broad range of therapeutic areas and imaging modalities.